Fundraising Fox

Progenity

San Diego, US · Founded 2012 · Delaware corporation

Healthtech

Founders & leadership

HS
HOWARD SLUTSKYExecutive
EF
ERIC FOXExecutive
CN
CLARKE NEUMANNExecutive
HG
HARRY G. STYLLINamed on SEC filing

Board

JA
JEFFREY A. FERRELLBoard director

Funding

SEC filings, press & company announcements

$128.1M disclosed across 5 of 9 rounds · 2015–2026

▶$10MraisedApr 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey FerrellDirector
  • Clarke NeumannExecutive Officer
  • John BigalkeDirector
  • Lynne PowellDirector
  • Eric d'EsparbesExecutive Officer
  • Eric FoxExecutive Officer
  • Samuel NussbaumDirector
  • Harry StylliExecutive Officer, Director
  • Jeffrey AlterDirector
  • Brian KotzinDirector
Offering amount
$60M
Amount sold
$10M
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$31.1MraisedNov 2019 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Harry StylliExecutive Officer, Director, Promoter
  • Howard SlutskyDirector
  • Eric d'EsparbesExecutive Officer
  • Eric FoxExecutive Officer
  • Clarke NeumannExecutive Officer
  • Lynne PowellDirector
  • Jeffrey AlterDirector
  • John BigalkeDirector
  • Brian KotzinDirector
  • Samuel NussbaumDirector
  • Jeffrey FerrellDirector
Offering amount
$105.5M
Amount sold
$31.1M
First sale
Nov 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25MraisedSep 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian KotzinDirector
  • Samuel NussbaumDirector
  • Lynne PowellDirector
  • Harry StylliExecutive Officer, Director, Promoter
  • Howard SlutskyDirector
  • John BigalkeDirector
  • Eric FoxExecutive Officer
  • Clarke NeumannExecutive Officer
  • Jeffrey FerrellDirector
  • Jeffrey AlterDirector
  • Eric d'EsparbesExecutive Officer
Offering amount
$100M
Amount sold
$25M
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50MraisedNov 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric FoxExecutive Officer
  • Clarke NeumannExecutive Officer
  • Howard SlutskyExecutive Officer, Director, Promoter
  • Harry StylliExecutive Officer, Director, Promoter
  • Sumit AggarwalExecutive Officer
  • Jeffrey FerrellDirector
Offering amount
$55M
Amount sold
$50M
First sale
Oct 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedAug 2016 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric FoxExecutive Officer
  • Sumit AggarwalExecutive Officer
  • Clarke NeumannExecutive Officer
  • Harry StylliExecutive Officer, Director, Promoter
  • Howard SlutskyExecutive Officer, Director, Promoter
  • Paul HawranPromoter
  • Jeffrey FerrellDirector
Offering amount
$12M
Amount sold
$12M
First sale
Aug 2016
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedJun 2015 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • JEFFREY A. FERRELLDirector
  • HOWARD SLUTSKYExecutive Officer, Director
  • ERIC FOXExecutive Officer
  • CLARKE NEUMANNExecutive Officer
  • HARRY G. STYLLIExecutive Officer, Director
First sale
Jun 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Progenity Raises $125M in Series B Financing | Chief Healthcare Executivechiefhealthcareexecutive.com · Jun 2026BTIG raises Progenity stock price target to $31 from $27, maintains Sell rating By Investing.cominvesting.com · Oct 2025Capital Raises Add Confidence to Fast-Moving Biotech Progenity | Nasdaqnasdaq.com · Aug 2022Progenity : Raises $20 Million from Share Offering - MarketScreeneruk.marketscreener.com · Oct 2021Progenity Raises $40M in Private Placement | Genomewebgenomeweb.com · Jun 2021Progenity Receives Funding from Crohn’s & Colitis Foundation IBD Ventures Fund to Develop Drug Delivery System for IBD | Crohn's & Colitis Foundationcrohnscolitisfoundation.org · May 2021

Frequently asked questions

How much funding has Progenity raised?
Progenity has disclosed $128.1M raised across 5 of its 9 known rounds.
Where is Progenity headquartered?
Progenity is headquartered in San Diego, US.